Organization: Endiatx
Country: U.S.
Website: endiatx.com/
Year Founded: 2019
Number of Employees: 11-50
Innovation Class: Technology
In 2024, Endiatx introduced its groundbreaking PillBot, a micro-robotic capsule poised to transform gastrointestinal (GI) diagnostics and treatment. This vitamin-sized robot offers a non-invasive, cost-effective alternative to traditional endoscopies, addressing the significant burden of unnecessary invasive procedures. PillBot transmits live video as it navigates a water-filled stomach, allowing remote physician control via a game controller. This technology eliminates the need for sedation and hospital visits, significantly reducing patient discomfort and healthcare costs. Clinical trials have demonstrated PillBot’s efficacy and safety, paving the way for anticipated FDA clearance in 2025 and a US commercial launch in early 2026. The Hayward, Calif.-based company is planning for global expansion. The only current competitors to PillBot are magnetically controlled remote cameras that require the patient to remain still inside an MRI-like control machine during the examination. PillBot offers a more comfortable outpatient experience for the patient while delivering immediate feedback to the doctor.
The potential impact is profound, particularly in regions with limited access to GI care. Endiatx envisions integrating AI to enhance PillBot’s capabilities, enabling autonomous scanning, data analysis, and early disease detection, including stomach cancer. It said this approach promises to streamline diagnostics and improve patient outcomes.
Endiatx co-founder Torrey Smith dramatically demonstrated the PillBot live on stage during his keynote speech at RoboBusiness 2024. Audience members were able to witness Smith swallow the PillBot and then see live images from it projected on large screens.
Endiatx asserted that it is dedicated to patient-centric solutions. PillBot demonstrates the power of micro-robotics and AI to revolutionize GI care and establish a new standard for non-invasive diagnostics.
Explore the RBR50 Robotics Innovation Awards 2025.